Last reviewed · How we verify
NCT05240794
Effects of Therapeutic Mobile Game on Anxiety
NA trial testing ABM-01 in Social Anxiety Disorder in 150 participants. Completed in 31 May 2023.
31 May 2023
Quick facts
| Lead sponsor | Hunter College of City University of New York |
|---|---|
| Phase | NA |
| Status | Completed |
| Study type | INTERVENTIONAL |
| Allocation | randomized |
| Design | parallel |
| Masking | double |
| Primary purpose | treatment |
| Enrollment | 150 |
| Start date | 15 June 2022 |
| Primary completion | 31 May 2023 |
| Estimated completion | 31 May 2023 |
| Sites | 1 location across United States |
Drugs / interventions tested
- ABM-01
- Digital Control
Conditions studied
- Social Anxiety Disorder — all drugs for Social Anxiety Disorder →
Sponsor
Hunter College of City University of New York
Who can join
Adults 22 to 65, any sex, with Social Anxiety Disorder. Patients with the condition only — healthy volunteers not accepted.
Sponsor's own description
Participants with Social Anxiety Disorder (SAD) will use a digital therapeutic for 30 days, and will complete assessments measuring a broad range of anxiety and mood-related symptoms, with a focus on SAD symptoms, and metrics of functional impairment during this time. After the treatment period, participants will be followed at 6 month and 12 month after the completion of the study.
Publications & conference data
No peer-reviewed publications indexed yet for this trial. Completed trials usually publish results within 12-18 months.
Verify or expand the search:
- PubMed search for NCT05240794
- Europe PMC full search
- ASCO Meeting Library
- ESMO Meeting Library
- bioRxiv preprints
- medRxiv preprints
- Google Scholar
Related trials
Other recruiting trials for Social Anxiety Disorder
Currently open trials in the same condition.
- NCT06661460 — Internet-Delivered Cognitive Behavioral Intervention for Youths With Anxiety Disorders · NA · recruiting
- NCT06934525 — Implementing Team-Based Treatment for Pediatric Anxiety in Community Mental Health Settings · NA · recruiting
- NCT06274112 — Using TMS to Understand Neural Processes of Social Motivation · NA · recruiting
- NCT06942429 — Stepped Versus Stratified Care for Anxiety Disorders in Youth · NA · recruiting
- NCT06514495 — Differential Effects of in Vivo and Virtual Exposure Therapy in Agoraphobia · NA · recruiting
Other Hunter College of City University of New York trials
Trials by the same sponsor.
- NCT06860932 — A Palliative Care Model Impact on Knowledge and Attitudes · NA · recruiting
- NCT06505421 — Eccentric Exercise and Fatigue in Multiple Sclerosis · recruiting
- NCT06126107 — Gain and Loss Framed Text Messaging to Reduce Drinking Among Older Adults · NA · completed
- NCT06094855 — Effect of Cooling on Balance Performance in Multiple Sclerosis · recruiting
- NCT05544578 — Korean Translation and Validation of the K-HEPI in NYC · NA · completed
Verify against primary sources
- ClinicalTrials.gov — authoritative US registry record
- WHO ICTRP — international registry index
- EU Clinical Trials Register
- Sponsor press releases (Google)
- Trial protocol + status: ClinicalTrials.gov NCT05240794 (US National Library of Medicine, public domain)
- Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
- Sponsor: as reported to ClinicalTrials.gov by Hunter College of City University of New York
- Last refreshed: 5 October 2023
Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT05240794.
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing